RELIEF Patient Registry Study: Rapid Evaluation of Lifestyle, Independence, and Elimination of breakthrough cancer pain with Freedom from oral discomfort through the use of Abstral (fentanyl) sublingual tablets

Trial Profile

RELIEF Patient Registry Study: Rapid Evaluation of Lifestyle, Independence, and Elimination of breakthrough cancer pain with Freedom from oral discomfort through the use of Abstral (fentanyl) sublingual tablets

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Sep 2013

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Acronyms RELIEF
  • Most Recent Events

    • 04 Sep 2013 New trial record
    • 03 Sep 2013 Recruitment and enrolment for Galena Biopharma's Institutional Review Board (IRB)-approved cancer registry trial is underway, according to a company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top